Skip to main content

Table 2 Literature search results for research question 2

From: Focused allergic rhinitis practice parameter for Canada

 

Systematic Reviews

Randomized Controlled Trials

Clinical Practice Guidelines

OAH & INCS

OAH

INCS

OAH & INCS

OAH

INCS

Brożek et al., 2017 [56]

Juel-Berg et al., 2017 [62]

Huang et al., 2019 [61]

Donaldson et al., 2020 [57]

Wartna et al., 2017 [82]

Hashiguchi et al., 2017 [59]

Ellis et al., 2016 [58]

Dykewicz et al., 2017 [4]

Meltzer et al., 2021 [67]

Liu et al., 2018 [65]

Hoang et al., 2022 [60]

 

Locks et al., 2017 [66]

Karaulov et al., 2019 [63]

Dykewicz et al., 2020 [5]

Zhang et al., 2022 [88]

Miligkos et al., 2021 [68]

Khattiyawittayakun et al., 2019 [64]

 

Nayak et al., 2017 [69]

Ng et al., 2021 [70]

Scadding et al., 2017 [40]

 

Singh Randhawa et al., 2021 [77]

Phinyo et al., 2022 [76]

 

Nourollahian et al., 2020 [71]

Noyama et al., 2016 [73]

Wise et al., 2018 [50]

 

Tiamkao et al., 2021 [79]

Valenzuela et al., 2019 [80]

 

Novak et al., 2016 [72]

Thongngarm et al., 2021 [78]

  

Velentza et al., 2020 [81]

Wu et al., 2019 [84]

 

Okubo et al., 2019 [75]

Zieglmayer et al., 2020 [90]

  

Wei, 2016 [83]

  

Okubo et al., 2017 [74]

Zhang et al., 2021 [89]

  

Xiao et al., 2016 [85]

  

Yamprasert et al., 2020 [86]

 
     

Yonekura et al., 2019 [87]

 
  1. INCS, intranasal corticosteroid; OAH, oral antihistamine